SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Company disclosed preliminary NAV per share of $19.13 as of June 30, 2026, along with total investments of $2.2 billion and a debt-to-equity ratio of 1.05x, providing material financial metrics for investor assessment of the registrant's financial position and leverage.
View raw filing on EDGAR →The filing discloses an unregistered sale of 9,457,500 Class A shares and 3,690,759 Class E shares for aggregate consideration of approximately $131.5 million, conducted under Section 4(a)(2) and Regulation D Rule 506. This is a classic private placement of equity securities exempt from registration, which is material to investors as it represents significant dilution and capital raising activity.
View raw filing on EDGAR →BV Financial issued a press release on July 24, 2026 announcing quarterly and six-month financial results for the period ended June 30, 2026, disclosing net income of $3.5 million ($0.42 per diluted share) for Q2 2026 and $4.6 million ($0.55 per diluted share) year-to-date, along with detailed financial condition and results of operations discussion. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →Bain Capital Private Credit declared a regular distribution of $0.1875 per share for Class I common shares, payable to shareholders of record as of July 31, 2026, with payment on or about August 31, 2026.
View raw filing on EDGAR →The Fund disclosed its NAV per share ($25.89 for Class I Shares as of June 30, 2026), aggregate NAV ($1,136.9 million), portfolio composition (182 companies, $2,216.4 million fair value), debt-to-equity ratios, and share subscription/repurchase activity.
View raw filing on EDGAR →Berkshire Hathaway completed its acquisition of Taylor Morrison Home Corp for $72.50 per share in cash, representing approximately $6.8 billion in equity value and $8.5 billion in enterprise value, on July 24, 2026. Taylor Morrison became a wholly owned subsidiary of Berkshire Hathaway, with its homebuilding brands unified with Berkshire's Clayton Properties Group operations.
View raw filing on EDGAR →Taylor Morrison notified the NYSE of the anticipated completion of the Berkshire Hathaway merger and requested suspension of trading and delisting of TMHC Common Stock from the NYSE, effective August 3, 2026. The company intends to file Form 15 to terminate registration under Section 12(g) and suspend reporting obligations.
View raw filing on EDGAR →MannKind entered into a Securities Purchase Agreement on July 23, 2026, to sell 10,440,838 shares of common stock at $3.89 per share and 2,412,632 pre-funded warrants at $3.88 per warrant in a private placement, raising approximately $50 million in gross proceeds. The unregistered sale under Section 4(a)(2) of the Securities Act represents a dilutive equity issuance, with proceeds intended for general corporate purposes including a $45 million contingent value rights payment triggered by FDA approval of Furoscix ReadyFlow.
View raw filing on EDGAR →Invivyd received a deficiency letter from Nasdaq on July 23, 2026, notifying the company that its stock bid price closed below the $1.00 minimum for 30 consecutive business days, triggering Nasdaq Listing Rule 5450(a)(1). The company has until January 19, 2027 to regain compliance or faces potential delisting, with the possibility of a second compliance period only if it transfers to the Nasdaq Capital Market. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →FibroBiologics received a Staff Determination from Nasdaq on July 22, 2026, notifying the company of its determination to delist the company's securities from The Nasdaq Capital Market due to failure to maintain the minimum bid price of $1.00 per share required by Nasdaq Listing Rule 5550(a)(2). The company's bid price closed below $1.00 for 30 consecutive business days (June 8–July 21, 2026) and is ineligible for the standard 180-day compliance period due to a prior reverse stock split. Unless the company appeals by July 29, 2026, delisting and suspension are scheduled for July 31, 2026. This is a quintessential delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →The filing discloses that the Company's delisting from the NYSE triggered defaults under subordinated convertible debt instruments held by GPO and YA, and that the Company has negotiated forbearance agreements to waive and delay enforcement of these defaults until August 22, 2026. This is a covenant breach event—a triggering event that accelerates or increases a direct financial obligation—even though the creditors have agreed to forbear. The delisting-triggered default is the material event; the forbearance is the Company's response to it.
View raw filing on EDGAR →The filing discloses Amendment No. 5 to a Master Repurchase Agreement with JPMorgan Chase, extending the maturity date from July 21, 2026 to July 21, 2028, with a final maturity cap of July 21, 2030. While technically an amendment to an existing debt facility rather than a new issuance, this represents a material modification of a direct financial obligation—extending the repayment term by two years and requiring a $625,000 extension fee. The amendment preserves the underlying repurchase obligation and security interests, making it a material refinancing event affecting the company's debt structure and liquidity profile.
View raw filing on EDGAR →Odyssey Marine received notice from Nasdaq on July 21, 2026 that it failed to satisfy the $1.00 minimum bid price requirement for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2). The company has until January 19, 2027 to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued listing status.
View raw filing on EDGAR →PennantPark Private Income Fund completed an unregistered sale of 31,142 common shares for approximately $805,000 to accredited investors pursuant to Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →The Company disclosed its net asset value per share of $25.85 and aggregate net asset value of $124.3 million as of June 30, 2026.
View raw filing on EDGAR →Range Capital issued an unsecured promissory note in the principal amount of up to $540,000 to its sponsor on June 18, 2026, with $120,000 outstanding as of July 23, 2026. This constitutes creation of a new direct financial obligation. Although the note is sponsor-related and tied to trust account funding for a SPAC, it remains a material debt instrument with defined repayment terms and events of default, fitting the debt_issuance category.
View raw filing on EDGAR →Interactive Strength exercised Class B Incremental Warrants resulting in the issuance of a $2,000,000 convertible note and 305,810 common stock warrants with favorable conversion terms (110% uplift, alternate conversion at 85% of VWAP in default) and low conversion prices ($3.597 and $5.527 per share), representing a material dilutive capital raise through an unregistered private placement under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Standard BioTools received a formal notice from Nasdaq on July 22, 2026, indicating failure to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days (until January 19, 2027) to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued listing status and trading viability.
View raw filing on EDGAR →On July 21, 2026, the Company entered into an exchange agreement whereby existing stockholders exchanged 392,766 shares of common stock for pre-funded warrants to purchase the same number of shares at $0.0001 per share, relying on Section 3(a)(9) exemption. The transaction restructures the capital stack and materially increases potential dilution, particularly given the warrants' minimal exercise price and RTW Investments' significant existing stake of approximately 38% post-Exchange.
View raw filing on EDGAR →The Company terminated a Securities Purchase and Exchange Agreement dated November 11, 2025, whereby RTW funds were to exchange outstanding indebtedness (convertible notes and revenue interest financing agreements) for Series B Perpetual Convertible Preferred Stock. The transaction failed to close by the February 28, 2026 deadline, leaving the underlying debt obligations outstanding and materially affecting the company's capital structure.
View raw filing on EDGAR →Apollo Asset Backed Credit Company LLC completed unregistered sales of equity securities totaling approximately $48.3 million across Series I and Series II share classes to third-party investors as of July 1, 2026, exempt from registration under Section 4(a)(2) and Regulations D and S.
View raw filing on EDGAR →The company announced determination of Net Asset Value per share across multiple share classes as of June 30, 2026, declared quarterly distributions with specific per-share amounts, announced the quarterly share repurchase program with pricing and deadlines, and implemented a shift to Transactional Net Asset Value methodology effective July 1, 2026.
View raw filing on EDGAR →Ms. Mary Ann E. Moore, Executive Vice President, General Counsel, Chief Administrative Officer and Secretary, is departing the Company effective October 31, 2026, pursuant to a Separation Agreement executed on July 21, 2026, classified as a termination without cause with severance benefits.
View raw filing on EDGAR →Mr. David Haddock has been appointed as Executive Vice President, General Counsel and Secretary of Pediatrix Medical Group, Inc., assuming the senior leadership role vacated by Ms. Moore's departure.
View raw filing on EDGAR →The Company entered into an Underwriting Agreement on July 21, 2026 for the issuance and sale of $750,000,000 aggregate principal amount of 4.950% Senior Notes due 2031. This is a material creation of a direct financial obligation through debt issuance, disclosed under Item 8.01 (Other Events) with the underwriting agreement attached as an exhibit. The $750 million principal amount and senior note status make this a material capital event for a reasonable investor.
View raw filing on EDGAR →Silicon Motion confirms its quarterly cash dividend payment of $0.50 per ADS (equivalent to $0.125 per ordinary share) to be paid on August 20, 2026 to shareholders of record on August 6, 2026. This is a routine but material dividend distribution announcement, as it represents a return of capital to shareholders pursuant to the Board's October 27, 2025 declaration of an annual dividend of US$2.00 per ADS paid in quarterly installments.
View raw filing on EDGAR →Surf Air Mobility held its Annual Meeting of Stockholders on July 24, 2026, with voting results including the election of two Class C directors (Tyler Painter and Sudhin Shahani), ratification of PwC as independent auditor, and approval of a reverse stock split authorization (2:1 to 6:1 ratio).
View raw filing on EDGAR →The Company received notice from the NYSE on July 24, 2026, of non-compliance with Section 802.01C of the NYSE Listed Company Manual due to its average closing stock price falling below $1.00 over a consecutive 30 trading-day period, triggering a six-month cure period.
View raw filing on EDGAR →Alexander Fink was elevated to principal executive officer with expanded responsibilities including HR, finance, and operations, effective immediately with direct Board reporting. The filing also discloses concurrent promotions of Garrett Kasper to Chief Communications Officer and a strategic role shift for Serhii Kupriienko to lead the newly created Swarmer Labs innovation division.
View raw filing on EDGAR →SoundHound AI disclosed receipt of all required foreign investment regulatory approvals (from Bulgaria, Canada, Italy, Germany, and United Kingdom) for its previously announced merger with LivePerson. The filing confirms that "the receipt of the foregoing foreign investment approvals satisfies all regulatory approval conditions to the closing of the Mergers," with the transaction now subject only to LivePerson stockholder approval before consummation. This represents a material milestone in a significant M&A transaction that would result in LivePerson becoming an indirect wholly owned subsidiary of SoundHound.
View raw filing on EDGAR →Huachen AI is seeking shareholder approval at an Extraordinary General Meeting scheduled for August 18, 2026, to increase the voting rights of Class B Ordinary Shares from 30 to 200 votes per share and to adopt amended and restated memorandum and articles of association to reflect this material change to the company's capital structure and governance framework.
View raw filing on EDGAR →The exhibit announces a concurrent registered direct offering of 1,281,646 ADSs (384.5 million ordinary shares) at US$3.16 per ADS for US$4.1 million gross proceeds, plus unregistered warrants and an Australian private placement and share purchase plan totaling up to A$12.7 million. This is a material dilutive equity issuance to accredited institutional investors under Section 4(a)(2) and Regulation D, with warrants exercisable at US$3.79 per ADS expiring July 31, 2029, and options at A$0.018 per option. The offering is subject to shareholder approval at an extraordinary general meeting scheduled for September 11, 2026.
View raw filing on EDGAR →FangDD received a Nasdaq deficiency notification on July 22, 2026, for failure to maintain the minimum bid price of US$1 per share for 30 consecutive business days. The company has been granted a 180-day compliance period until January 19, 2027, to regain compliance or face potential delisting. This is a material disclosure under Item 3.01 (Delisting Risk) as it directly threatens the company's continued listing on Nasdaq and would significantly affect investor assessment of the registrant's status.
View raw filing on EDGAR →The 6-K discloses that Haoxin Holdings has failed to regain compliance with Nasdaq's minimum bid price requirement ($1.00 per share) during the first 180-calendar-day cure period and has been granted an additional 180-day extension until December 14, 2026. The filing explicitly warns that failure to regain compliance within this period will result in delisting notice, with only an appeal right to a Nasdaq hearings panel offering uncertain relief. This is a material delisting risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →This press release announces a new product order from a third business unit of a Tier-1 Israeli defense company for ParaZero's DefendAir Net Pod system, including engineering support for integration into an autonomous Counter-UAS platform. The disclosure emphasizes this is the third business unit within the same customer to order the technology, signaling expanding adoption and market traction. While not a discrete M&A transaction, debt issuance, or earnings release, this represents a material operational/commercial milestone—a significant customer order that demonstrates product-market validation and revenue generation potential for a defense technology company.
View raw filing on EDGAR →The Company discloses that the NYSE has determined to commence delisting proceedings for its warrants (ticker VLNW) effective July 24, 2026, based on "abnormally low selling price" under NYSE Listed Company Manual Section 802.01D. Trading in the warrants will be suspended, though the ordinary shares (VLN) remain listed. This is a delisting notice that materially affects the status of a security class.
View raw filing on EDGAR →RMX Industries effected a 1-for-3 reverse stock split of its Class A and Class B common stock, effective July 24, 2026, reducing authorized shares and automatically adjusting all equity awards, warrants, and derivatives. The reverse split is a material governance action undertaken to increase share price and improve marketability in preparation for an intended uplisting to a national securities exchange (NYSE American), with a $50 million contingent financing facility tied to the uplisting.
View raw filing on EDGAR →The 6-K discloses a 1-for-11 reverse stock split effective July 31, 2026, which consolidates 6,132,100 shares into approximately 557,464 shares. While a reverse split itself is a capital structure adjustment rather than a new issuance, the filing also references recent dilutive equity issuances (June 2026 PIPE private placement and June 2026 convertible note) and adjustments to warrant exercise prices, signaling capital-raising activity and shareholder dilution. The reverse split is typically undertaken to address low stock price and maintain listing compliance, often following dilutive financings. The materiality lies in the capital structure change and its implications for existing shareholders.
View raw filing on EDGAR →AMR Resources Acquisition Corp consummated its IPO on July 16, 2026, issuing 26,000,000 units (including 1,000,000 from over-allotment exercise) at $10.00 per unit for $260 million in gross proceeds, plus 707,500 private placement units for $7.075 million. This is a material capital raise through equity issuance. While technically a SPAC IPO (blank-check company), the disclosure centers on the issuance of equity securities and capital raised, which fits the dilutive_issuance category. The alternative classification would be operational_other (as a SPAC formation event), but the primary material event disclosed is the equity capital raise itself.
View raw filing on EDGAR →The press release discloses that the European Investment Bank has executed a waiver deferring an approximately €1.7 million loan payment due July 28, 2026, under the Company's March 2021 credit facility. The waiver indicates the parties are "advancing toward a full and final settlement" expected to "reduce Brenmiller's debt." While the language emphasizes constructive negotiations, the need for a waiver of a scheduled payment obligation and the ongoing settlement discussions signal a triggering event or technical default that would normally accelerate or increase a direct financial obligation—the hallmark of covenant_breach. The materiality is clear: the disclosure addresses debt restructuring, balance-sheet strengthening, and liquidity preservation, all material to investor assessment.
View raw filing on EDGAR →Faraday Future implemented a 1-for-150 reverse stock split as a proactive risk management measure to avoid Nasdaq delisting, which would be triggered if the stock price fell to $0.10 or below for 10 consecutive trading days. The company disclosed that its closing bid price had approached this critical threshold, and the reverse split was designed to safeguard the Nasdaq listing and preserve liquidity and access to capital.
View raw filing on EDGAR →VivoSim Labs received a written notice from Nasdaq on July 20, 2026, indicating failure to meet the minimum $2,500,000 stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). The company has 45 days to submit a compliance plan and faces potential delisting if compliance is not regained within 180 days.
View raw filing on EDGAR →VivoSim Labs closed a private placement on July 17, 2026, issuing pre-funded warrants and common warrants to purchase approximately 4.7 million shares of common stock for gross proceeds of $4.0 million.
View raw filing on EDGAR →Lauren Selig was appointed as a director of Renatus Tactical Acquisition Corp I effective July 21, 2026, and simultaneously appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. The filing discloses her extensive background in entertainment, technology, AI, blockchain, and venture investment, along with her current board service at XPRIZE and Pendrell Corporation. This is a clear executive appointment event material to investors assessing the company's governance and board composition.
View raw filing on EDGAR →The filing discloses the resignation of Ham, Langston & Brezina, LLP as the Company's independent registered public accounting firm on July 20, 2026, and the appointment of CohnReznick LLP as the new auditor on July 23, 2026. This is a classic auditor change under Item 4.01. The prior auditor's reports contained an explanatory paragraph regarding going-concern uncertainty, which adds materiality to the transition, though no disagreements or reportable events are disclosed.
View raw filing on EDGAR →The 6-K discloses results of an extraordinary general meeting held on July 15, 2026, where shareholders voted on two resolutions: (1) a capital reorganisation involving a reduction of par value from US$1.25 to US$0.00001 per share and subdivision of authorised shares, and (2) an amendment to the 2025 Omnibus Equity Plan to increase available shares by 15 million and add an evergreen provision. Both proposals were approved with vote tallies provided. This is a classic shareholder vote results disclosure material to investors assessing capital structure and equity dilution.
View raw filing on EDGAR →The press release announces a registered direct offering of 4.5 million units (each consisting of one Class A ordinary share and one common warrant) at $2.00 per unit, generating approximately $9 million in gross proceeds. This is a classic dilutive equity issuance to institutional investors under a shelf registration statement (Form F-3), materially diluting existing shareholders and raising capital through the sale of registered securities.
View raw filing on EDGAR →GCL Global Holdings Ltd is soliciting shareholder votes at an extraordinary general meeting scheduled for August 7, 2026, on four substantive proposals: authorization for a 10:1 to 30:1 share consolidation with board discretion on timing and ratio, increase in authorized share capital post-consolidation, adoption of amended memorandum and articles of association, and meeting adjournment authority. The share consolidation and capital restructuring represent material governance and capital structure events affecting investor assessment.
View raw filing on EDGAR →The 6-K discloses a private placement (PIPE transaction) in which INLIF Limited issued 40,000 Class B ordinary shares to Kerui Enterprise Limited at $2.58 per share for $103,200 in gross proceeds on July 22, 2026. The shares were issued pursuant to Section 4(a)(2) of the Securities Act and Regulation S, explicitly unregistered. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Jonathan Bock resigned from his role as Co-Chief Executive Officer of Blackstone Private Credit Fund on July 20, 2026. This is a clear executive departure of a named officer at the C-suite level. The filing explicitly states the departure was not due to disagreement, but the resignation of a Co-CEO is material to investors' assessment of the fund's leadership and governance.
View raw filing on EDGAR →